Aclarion, Inc. (ACON) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Healthcare Information Services industria. La empresa tiene su sede en Broomfield, CA, United States. El CEO actual es Brent Ness.
ACON tiene fecha de IPO 2022-04-22, 5 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $1.74M.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
